Logo image of NXE.CA

NEXGEN ENERGY LTD (NXE.CA) Stock Fundamental Analysis

Canada - TSX:NXE - CA65340P1062 - Common Stock

12.27 CAD
-0.05 (-0.41%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

2

Overall NXE gets a fundamental rating of 2 out of 10. We evaluated NXE against 210 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of NXE have multiple concerns. NXE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NXE has reported negative net income.
In the past year NXE has reported a negative cash flow from operations.
NXE had negative earnings in 4 of the past 5 years.
NXE had a negative operating cash flow in each of the past 5 years.
NXE.CA Yearly Net Income VS EBIT VS OCF VS FCFNXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

NXE has a worse Return On Assets (-12.53%) than 63.33% of its industry peers.
NXE has a Return On Equity of -18.89%. This is in the lower half of the industry: NXE underperforms 62.86% of its industry peers.
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE.CA Yearly ROA, ROE, ROICNXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NXE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE.CA Yearly Profit, Operating, Gross MarginsNXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

NXE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXE has more shares outstanding
NXE has a worse debt/assets ratio than last year.
NXE.CA Yearly Shares OutstandingNXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE.CA Yearly Total Debt VS Total AssetsNXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NXE has an Altman-Z score of 7.47. This indicates that NXE is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.47, NXE belongs to the best of the industry, outperforming 89.05% of the companies in the same industry.
NXE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
NXE has a Debt to Equity ratio of 0.01. This is in the better half of the industry: NXE outperforms 79.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 7.47
ROIC/WACCN/A
WACCN/A
NXE.CA Yearly LT Debt VS Equity VS FCFNXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

NXE has a Current Ratio of 0.75. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
NXE has a Current ratio (0.75) which is comparable to the rest of the industry.
NXE has a Quick Ratio of 0.75. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
NXE's Quick ratio of 0.75 is in line compared to the rest of the industry. NXE outperforms 54.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
NXE.CA Yearly Current Assets VS Current LiabilitesNXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.52% over the past year.
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NXE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -8.36% yearly.
Based on estimates for the next years, NXE will show a very strong growth in Revenue. The Revenue will grow by 59.79% on average per year.
EPS Next Y-29.86%
EPS Next 2Y3.93%
EPS Next 3Y-8.65%
EPS Next 5Y-8.36%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y59.79%

3.3 Evolution

NXE.CA Yearly Revenue VS EstimatesNXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2029 2030 2031 2032 1B 2B 3B
NXE.CA Yearly EPS VS EstimatesNXE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE.CA Price Earnings VS Forward Price EarningsNXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE.CA Per share dataNXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -8.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.93%
EPS Next 3Y-8.65%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

TSX:NXE (10/10/2025, 7:00:00 PM)

12.27

-0.05 (-0.41%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners58.72%
Inst Owner ChangeN/A
Ins Owners4.68%
Ins Owner ChangeN/A
Market Cap6.99B
Analysts81.18
Price Target13.95 (13.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-296.04%
Max EPS beat(2)241.44%
EPS beat(4)2
Avg EPS beat(4)-39.73%
Min EPS beat(4)-296.04%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-68.3%
EPS beat(12)4
Avg EPS beat(12)-151.78%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.89%
PT rev (3m)2.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.99%
EPS NY rev (1m)-29.95%
EPS NY rev (3m)-95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.81
P/tB 6.81
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.19
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS1.8
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5507.06%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 7.47
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y-29.86%
EPS Next 2Y3.93%
EPS Next 3Y-8.65%
EPS Next 5Y-8.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y59.79%
EBIT growth 1Y47.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.28%
EBIT Next 3Y2.63%
EBIT Next 5Y4.7%
FCF growth 1Y-28.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.24%
OCF growth 3YN/A
OCF growth 5YN/A